NOVEL ADVERSE EVENTS OF CGRP RECEPTOR ANTAGONISTS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE

被引：0
|
作者：
Sangnure, A. [1 ]
Das, A. [1 ]
Sajjan, S. [1 ]
Ac, R. [1 ]
机构：
[1] MS Ramaiah Univ Appl Sci, Bengaluru, KA, India
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD65
引用
收藏
页码：S372 / S373
页数：2
相关论文
共 50 条
  • [1] Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Elsa
    ASIAN JOURNAL OF PSYCHIATRY, 2017, 30 : 152 - 156
  • [2] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [3] EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sharma, V
    Viswam S, K.
    Ravindra, Reddy N.
    Chacko, S.
    Bellapu, A.
    VALUE IN HEALTH, 2019, 22 : S592 - S593
  • [4] Vedolizumab associated haematochezia: A disproportionality analysis in USFDA adverse event reporting system database
    Bellapu, Anusha
    Viswam, Subeesh K.
    Sharma, Vasista
    Chacko, Stephy T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 464 - 464
  • [5] MEPOLIZUMAB INDUCED MYALGIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Chacko, S.
    Viswam, K. S.
    Reddy, Ravindra N.
    Sharma, V
    Bellapu, A.
    VALUE IN HEALTH, 2019, 22 : S882 - S882
  • [6] Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database A Disproportionality Analysis
    Shamloo, Behrooz K.
    Chhabra, Pankdeep
    Freedman, Andrew N.
    Potosky, Arnold
    Malin, Jennifer
    Smith, Sheila Weiss
    DRUG SAFETY, 2012, 35 (06) : 507 - 518
  • [7] BEVACIZUMAB INDUCED PULMONARY EMBOLISM: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Bellapu, A.
    Viswam, K. S.
    Reddy, Ravindra N.
    Chacko, S.
    Sharma, V
    VALUE IN HEALTH, 2019, 22 : S883 - S884
  • [8] POTENTIAL ASSOCIATION OF REMDESIVIR AND HYPERKALEMIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Das, A.
    Vajapu, M.
    VALUE IN HEALTH, 2023, 26 (06) : S172 - S172
  • [9] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [10] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
12345